Trial intelligence / Profile preview

Optimization of Treatment in Patients With Severe Peripheral Ischemia (Fontaine Stage IIb)

NCT01718288Phase 4Completed

Sponsor
Fondazione FADOI
Start
Nov 2006
Primary completion
Mar 2011
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of iloprost in Peripheral Arterial Disease (PAD), sponsored by Fondazione FADOI. Started Nov 2006; status: completed.

02

Drugs

iloprost
03

Conditions

Peripheral Arterial Disease (PAD)

Beyond the preview

Go deeper on NCT01718288.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01718288.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call